[1] Maxwell SRJ. Rational prescribing: the principles of drug selection. Clinical Medicine. 2016;16(5):459–64.
[2] Aronson J. Rational prescribing, appropriate prescribing. British journal of clinical pharmacology. 2004;57(3):229.
[3] Hudi RI, Ranti I. The Rationality of Antibiotic Use on Patients of Typhoid Fever. Mutiara Medika: Jurnal Kedokteran dan Kesehatan. 2020;20(1):1–5.
[4] Bachhav SS, Kshirsagar NA. Systematic review of drug utilization studies & the use of the drug classification system in the WHO-SEARO Region. Indian J Med Res. 2015;142(2):120–9.
[5] Truter I. A review of drug utilization studies and methodologies. Jordan journal of pharmaceutical sciences. 2008;1(2).
[6] Khamas SS, Darvishi F, Taghvaye-Masoumi H, Rafiei E, Jafari A. The utilization evaluation of intravenous pantoprazole for stress ulcer prophylaxis in a major teaching hospital. Journal of Pharmaceutical Care. 2022:128–35.
[7] Poole P. Pantoprazole. American journal of health-system pharmacy. 2001;58(11):999–1008.
[8] Sohrevardi S-M, Vahidi A, Mosadegh M-H, Dehghani-Tafti A, Dadollahi A. Evaluation of prescriptions and use of intravenous pantoprazole in general wards and intensive care unit of Shahid Sadoughi Hospital in Yazd. Journal of Pharmaceutical Care. 2015:7–10.
[9] Krag M, Marker S, Perner A, Wetterslev J, Wise MP, Schefold JC, et al. Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. New England Journal of Medicine. 2018;379(23):2199–208.
[10] Bezabeh S, Mackey AC, Kluetz P, Jappar D, Korvick J. Accumulating evidence for a drug–drug interaction between methotrexate and proton pump inhibitors. The oncologist. 2012;17(4):550–4.
[11] Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE. Side effects of long‐term proton pump inhibitor use: a review. Basic & clinical pharmacology & toxicology. 2018;123(2):114–21.
[12] Ra A, Tobe SW. Acute interstitial nephritis due to pantoprazole. Annals of Pharmacotherapy. 2004;38(1):41–5.
[13] Ahmadi H, Ahangar N, Saghafi F, Ala S, Eslami G, Salehifar E. Drug utilization evaluation of pantoprazole in a teaching hospital in North of Iran, 2016. Journal of Mazandaran University of Medical Sciences. 2018;28(162):69–76.
[14] Eslami G, Razkenar EK, Sharifi Y, Soleimani A, Salehifar E, Aliabadi PK. Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit. Pharmaceutical and Biomedical Research. 2021.
[15] Aramesh M, Hasanloie Mav, Aghlmand S, Sharifi H. Assessment of Stress Ulcer Prophylaxis Pattern in the Intensive Care Unit Patients. Journal of Critical and Intensive Care. 2022;13(1):8.
)